Publication list - Publika - Scientific publications from Oslo University Hospital

Publications by Magne K. Fagerhol

176 publications found

Original articles

Fagerhol MK, Schultz NH, Mirlashari MR, Wiedmann MKH, Nissen-Meyer LSH, Søraas AVL, Hetland G (2023)
DNase analysed by a novel competitive assay in patients with complications after ChAdOx1 nCoV-19 vaccination and in normal unvaccinated blood donors
Scand J Immunol, 98 (1), e13274
DOI 10.1111/sji.13274, PubMed 37676118

Hetland G, Fagerhol MK, Dimova-Svetoslavova VP, Mirlashari MR, Nguyen NT, Lind A, Kolset SO, Søraas AVL, Nissen-Meyer LSH (2022)
Inflammatory markers calprotectin, NETs, syndecan-1 and neopterin in COVID-19 convalescent blood donors
Scand J Clin Lab Invest, 82 (6), 481-485
DOI 10.1080/00365513.2022.2123387, PubMed 36151851

Hetland G, Fagerhol MK, Wiedmann MKH, Søraas AVL, Mirlashari MR, Nissen-Meyer LSH, Istre MS, Holme PA, Schultz NH (2022)
Elevated NETs and Calprotectin Levels after ChAdOx1 nCoV-19 Vaccination Correlate with the Severity of Side Effects
Vaccines (Basel), 10 (8)
DOI 10.3390/vaccines10081267, PubMed 36016155

Fagerhol MK, Johnson E, Tangen JM, Hollan I, Mirlashari MR, Nissen-Meyer LSH, Hetland G (2020)
NETs analysed by novel calprotectin-based assays in blood donors and patients with multiple myeloma or rheumatoid arthritis: A pilot study
Scand J Immunol, 91 (5), e12870
DOI 10.1111/sji.12870, PubMed 32034957

Nordal HH, Fagerhol MK, Halse AK, Hammer HB (2017)
Calprotectin (S100A8/A9) should preferably be measured in EDTA-plasma; results from a longitudinal study of patients with rheumatoid arthritis
Scand J Clin Lab Invest, 78 (1-2), 102-108
DOI 10.1080/00365513.2017.1419371, PubMed 29278951

Nordal HH, Brun JG, Halse AK, Jonsson R, Fagerhol MK, Hammer HB (2014)
The neutrophil protein S100A12 is associated with a comprehensive ultrasonographic synovitis score in a longitudinal study of patients with rheumatoid arthritis treated with adalimumab
BMC Musculoskelet Disord, 15, 335
DOI 10.1186/1471-2474-15-335, PubMed 25282581

Curran SA, Hollan I, Erridge C, Lappin DF, Murray CA, Sturfelt G, Mikkelsen K, Førre OT, Almdahl SM, Fagerhol MK, Goodyear CS, Riggio MP (2014)
Bacteria in the adventitia of cardiovascular disease patients with and without rheumatoid arthritis
PLoS One, 9 (5), e98627
DOI 10.1371/journal.pone.0098627, PubMed 24874661

Angel K, Provan SA, Fagerhol MK, Mowinckel P, Kvien TK, Atar D (2012)
Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study
Am J Hypertens, 25 (6), 644-50
DOI 10.1038/ajh.2012.12, PubMed 22378036

Fagerhol MK, Larsen A, Brun JG, Hammer HB, Angel K, Kvien TK, Kinne I, Madland TM (2012)
Large molecular size EDTA-resistant complexes containing S100A12, ERAC, in serum during inflammatory conditions
Scand J Clin Lab Invest, 72 (2), 129-36
DOI 10.3109/00365513.2011.643819, PubMed 22248048

Hammer HB, Fagerhol MK, Wien TN, Kvien TK (2011)
The soluble biomarker calprotectin (an S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with adalimumab
Arthritis Res Ther, 13 (5), R178
DOI 10.1186/ar3503, PubMed 22029973

Berg-Hansen P, Vandvik B, Fagerhol M, Holmøy T (2009)
Calprotectin levels in the cerebrospinal fluid reflect disease activity in multiple sclerosis
J Neuroimmunol, 216 (1-2), 98-102
DOI 10.1016/j.jneuroim.2009.09.006, PubMed 19800696

Ødegaard E, Davidson B, Elgaaen BV, Fagerhol MK, Engh V, Onsrud M, Staff AC (2008)
Circulating calprotectin in ovarian carcinomas and borderline tumors of the ovary
Am J Obstet Gynecol, 198 (4), 418.e1-7
DOI 10.1016/j.ajog.2007.10.792, PubMed 18241816

Larsen A, Bronstein IB, Dahl O, Wentzel-Larsen T, Kristoffersen EK, Fagerhol MK (2007)
Quantification of S100A12 (EN-RAGE) in blood varies with sampling method, calcium and heparin
Scand J Immunol, 65 (2), 192-201
DOI 10.1111/j.1365-3083.2006.01875.x, PubMed 17257225

Hammer HB, Odegard S, Fagerhol MK, Landewé R, van der Heijde D, Uhlig T, Mowinckel P, Kvien TK (2007)
Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis
Ann Rheum Dis, 66 (8), 1093-7
DOI 10.1136/ard.2006.064741, PubMed 17234650

Larsen A, Bjørge B, Klementsen B, Helgeland L, Wentzel-Larsen T, Fagerhol MK, Hovdenak N, Dahl O (2007)
Time patterns of changes in biomarkers, symptoms and histopathology during pelvic radiotherapy
Acta Oncol, 46 (5), 639-50
DOI 10.1080/02841860601099241, PubMed 17562440

Foster R, Kandanearatchi A, Beasley C, Williams B, Khan N, Fagerhol MK, Everall IP (2006)
Calprotectin in microglia from frontal cortex is up-regulated in schizophrenia: evidence for an inflammatory process?
Eur J Neurosci, 24 (12), 3561-6
DOI 10.1111/j.1460-9568.2006.05219.x, PubMed 17229104

Llohn AH, Vetlesen A, Fagerhol MK, Kjeldsen-Kragh J (2005)
The effect of pre-storage cooling on 2,3-DPG levels in red cells stored in SAG-M
Transfus Apher Sci, 33 (2), 113-8
DOI 10.1016/j.transci.2004.12.002, PubMed 16109505

Fessatou S, Fagerhol MK, Roth J, Stamoulakatou A, Kitra V, Hadarean M, Paleologos G, Chandrinou H, Sampson B, Papassotiriou I (2005)
Severe anemia and neutropenia associated with hyperzincemia and hypercalprotectinemia
J Pediatr Hematol Oncol, 27 (9), 477-80
DOI 10.1097/01.mph.0000179958.19524.9c, PubMed 16189440

Braekke K, Holthe MR, Harsem NK, Fagerhol MK, Staff AC (2005)
Calprotectin, a marker of inflammation, is elevated in the maternal but not in the fetal circulation in preeclampsia
Am J Obstet Gynecol, 193 (1), 227-33
DOI 10.1016/j.ajog.2004.11.055, PubMed 16021084

Holthe MR, Staff AC, Berge LN, Fagerhol MK, Lyberg T (2005)
Calprotectin plasma level is elevated in preeclampsia
Acta Obstet Gynecol Scand, 84 (2), 151-4
DOI 10.1111/j.0001-6349.2005.00554.x, PubMed 15683375

Fagerhol MK, Nielsen HG, Vetlesen A, Sandvik K, Lyberg T (2005)
Increase in plasma calprotectin during long-distance running
Scand J Clin Lab Invest, 65 (3), 211-20
DOI 10.1080/00365510510013587, PubMed 16095050

Splíchal I, Fagerhol MK, Trebichavský I, Splíchalová A, Schulze J (2005)
The effect of intestinal colonization of germ-free pigs with Escherichia coli on calprotectin levels in plasma, intestinal and bronchoalveolar lavages
Immunobiology, 209 (9), 681-7
DOI 10.1016/j.imbio.2004.09.009, PubMed 15804046

Larsen A, Hovdenak N, Karlsdottir A, Wentzel-Larsen T, Dahl O, Fagerhol MK (2004)
Faecal calprotectin and lactoferrin as markers of acute radiation proctitis: a pilot study of eight stool markers
Scand J Gastroenterol, 39 (11), 1113-8
DOI 10.1080/00365520410003614, PubMed 15545170

Kido J, Kido R, Suryono, Kataoka M, Fagerhol MK, Nagata T (2004)
Induction of calprotectin release by Porphyromonas gingivalis lipopolysaccharide in human neutrophils
Oral Microbiol Immunol, 19 (3), 182-7
DOI 10.1111/j.0902-0055.2004.00139.x, PubMed 15107070

Poullis A, Foster R, Shetty A, Fagerhol MK, Mendall MA (2004)
Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer risk
Cancer Epidemiol Biomarkers Prev, 13 (2), 279-84
DOI 10.1158/1055-9965.epi-03-0160, PubMed 14973103

Kido J, Kido R, Suryono, Kataoka M, Fagerhol MK, Nagata T (2003)
Calprotectin release from human neutrophils is induced by Porphyromonas gingivalis lipopolysaccharide via the CD-14-Toll-like receptor-nuclear factor kappaB pathway
J Periodontal Res, 38 (6), 557-63
DOI 10.1034/j.1600-0765.2003.00691.x, PubMed 14632917

Randen I, Hauge R, Kjeldsen-Kragh J, Fagerhol MK (2003)
Prenatal genotyping of RHD and SRY using maternal blood
Vox Sang, 85 (4), 300-6
DOI 10.1111/j.0042-9007.2003.00371.x, PubMed 14633256

Naess-Andresen CF, Ekeberg D, Fagerhol MK, Sandvik K, Staahl L (2003)
Isolation and partial characterisation of a new antiproliferative substance from human leucocytes inhibiting growth of Candida albicans
Mol Pathol, 56 (4), 232-6
DOI 10.1136/mp.56.4.232, PubMed 12890745

Schultz H, Csernok E, Herlyn K, Reichel PH, Moosig F, Cornely OA, Fagerhol MK, Gross WL (2003)
ANCA against bactericidal/permeability-increasing protein, azurocidin, calprotectin and defensins in rheumatic and infectious diseases: prevalence and clinical associations
Clin Exp Rheumatol, 21 (6 Suppl 32), S117-20
PubMed 14740437

Sampson B, Fagerhol MK, Sunderkötter C, Golden BE, Richmond P, Klein N, Kovar IZ, Beattie JH, Wolska-Kusnierz B, Saito Y, Roth J (2002)
Hyperzincaemia and hypercalprotectinaemia: a new disorder of zinc metabolism
Lancet, 360 (9347), 1742-5
DOI 10.1016/S0140-6736(02)11683-7, PubMed 12480428

Kristinsson J, Nygaard K, Sundseth A, Aadland E, Fagerhol MK (2002)
Comparison of faecal and intestinal concentrations of granulocyte marker protein and localization of gastrointestinal tumours in rats
Scand J Gastroenterol, 37 (9), 1029-33
DOI 10.1080/003655202320378211, PubMed 12374227

Aadland E, Fagerhol MK (2002)
Faecal calprotectin: a marker of inflammation throughout the intestinal tract
Eur J Gastroenterol Hepatol, 14 (8), 823-5
DOI 10.1097/00042737-200208000-00002, PubMed 12172400

Gemou-Engesaeth V, Fagerhol MK, Toda M, Hamid Q, Halvorsen S, Groegaard JB, Corrigan CJ (2002)
Expression of activation markers and cytokine mRNA by peripheral blood CD4 and CD8 T cells in atopic and nonatopic childhood asthma: effect of inhaled glucocorticoid therapy
Pediatrics, 109 (2), E24
DOI 10.1542/peds.109.2.e24, PubMed 11826234

Isaksen B, Fagerhol MK (2001)
Calprotectin inhibits matrix metalloproteinases by sequestration of zinc
Mol Pathol, 54 (5), 289-92
DOI 10.1136/mp.54.5.289, PubMed 11577169

Tibble J, Sigthorsson G, Foster R, Sherwood R, Fagerhol M, Bjarnason I (2001)
Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma
Gut, 49 (3), 402-8
DOI 10.1136/gut.49.3.402, PubMed 11511563

Welle I, Bakke PS, Eide GE, Fagerhol MK, Omenaas E, Gulsvik A (2001)
Increased circulating levels of alpha1-antitrypsin and calprotectin are associated with reduced gas diffusion in the lungs
Eur Respir J, 17 (6), 1105-11
DOI 10.1183/09031936.01.00067501, PubMed 11491151

Richter KK, Wang J, Fagerhol MK, Hauer-Jensen M (2001)
Radiation-induced granulocyte transmigration predicts development of delayed structural changes in rat intestine
Radiother Oncol, 59 (1), 81-5
DOI 10.1016/s0167-8140(00)00302-9, PubMed 11295210

Tibble J, Teahon K, Thjodleifsson B, Roseth A, Sigthorsson G, Bridger S, Foster R, Sherwood R, Fagerhol M, Bjarnason I (2000)
A simple method for assessing intestinal inflammation in Crohn's disease
Gut, 47 (4), 506-13
DOI 10.1136/gut.47.4.506, PubMed 10986210

Tibble JA, Sigthorsson G, Bridger S, Fagerhol MK, Bjarnason I (2000)
Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease
Gastroenterology, 119 (1), 15-22
DOI 10.1053/gast.2000.8523, PubMed 10889150

Kristinsson J, Røseth AG, Sundset A, Nygaard K, Løberg EM, Paulsen JE, Aadland E, Fagerhol MK (1999)
Granulocyte marker protein is increased in stools from rats with azoxymethane-induced colon cancer
Scand J Gastroenterol, 34 (12), 1216-23
DOI 10.1080/003655299750024733, PubMed 10636069

Fagerhol MK, Dobloug I (1999)
[Blood supply readiness in case of war or disasters]
Tidsskr Nor Laegeforen, 119 (21), 3159-60
PubMed 10522484

Tibble JA, Sigthorsson G, Foster R, Scott D, Fagerhol MK, Roseth A, Bjarnason I (1999)
High prevalence of NSAID enteropathy as shown by a simple faecal test
Gut, 45 (3), 362-6
DOI 10.1136/gut.45.3.362, PubMed 10446103

Røseth AG, Schmidt PN, Fagerhol MK (1999)
Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease
Scand J Gastroenterol, 34 (1), 50-4
DOI 10.1080/00365529950172835, PubMed 10048733

Hetland G, Talgö GJ, Fagerhol MK (1998)
Chemotaxins C5a and fMLP induce release of calprotectin (leucocyte L1 protein) from polymorphonuclear cells in vitro
Mol Pathol, 51 (3), 143-8
DOI 10.1136/mp.51.3.143, PubMed 9850337

Kristinsson J, Røseth A, Fagerhol MK, Aadland E, Schjønsby H, Børmer OP, Raknerud N, Nygaard K (1998)
Fecal calprotectin concentration in patients with colorectal carcinoma
Dis Colon Rectum, 41 (3), 316-21
DOI 10.1007/BF02237485, PubMed 9514426

Richter KK, Fagerhol MK, Carr JC, Winkler JM, Sung CC, Hauer-Jensen M (1997)
Association of granulocyte transmigration with structural and cellular parameters of injury in experimental radiation enteropathy
Radiat Oncol Investig, 5 (6), 275-82
DOI 10.1002/(SICI)1520-6823(1997)5:6<275::AID-ROI3>3.0.CO;2-V, PubMed 9436244

Birkeland KI, Donike M, Ljungqvist A, Fagerhol M, Jensen J, Hemmersbach P, Oftebro H, Haug E (1997)
Blood sampling in doping control. First experiences from regular testing in athletics
Int J Sports Med, 18 (1), 8-12
DOI 10.1055/s-2007-972587, PubMed 9059898

Homann C, Garred P, Graudal NA, Hasselqvist P, Christiansen M, Fagerhol MK, Thomsen AC (1996)
[Plasma calprotectin. A new prognostic marker of survival in alcoholic liver cirrhosis]
Ugeskr Laeger, 158 (21), 2980-4
PubMed 8686035

Fagerhol MK (1996)
Nomenclature for proteins: is calprotectin a proper name for the elusive myelomonocytic protein?
Clin Mol Pathol, 49 (2), M74-9
DOI 10.1136/mp.49.2.m74, PubMed 16696054

Golden BE, Clohessy PA, Russell G, Fagerhol MK (1996)
Calprotectin as a marker of inflammation in cystic fibrosis
Arch Dis Child, 74 (2), 136-9
DOI 10.1136/adc.74.2.136, PubMed 8660076

Saatvedt K, Lindberg H, Geiran OR, Michelsen S, Pedersen T, Seem E, Fagerhol M (1996)
Release of interleukin-8 and calprotectin during and after paediatric cardiopulmonary bypass with and without ultrafiltration
Scand J Thorac Cardiovasc Surg, 30 (2), 53-9
DOI 10.3109/14017439609107242, PubMed 8857675

Naess-Andresen CF, Egelandsdal B, Fagerhol MK (1995)
Calcium binding and concomitant changes in the structure and heat stability of calprotectin (L1 protein)
Clin Mol Pathol, 48 (5), M278-84
DOI 10.1136/mp.48.5.m278, PubMed 16696022

Homann C, Garred P, Graudal N, Hasselqvist P, Christiansen M, Fagerhol MK, Thomsen AC (1995)
Plasma calprotectin: a new prognostic marker of survival in alcohol-induced cirrhosis
Hepatology, 21 (4), 979-85
DOI 10.1016/0270-9139(95)90244-9, PubMed 7705809

Brun JG, Håland G, Haga HJ, Fagerhol MK, Jonsson R (1995)
Effects of calprotectin in avridine-induced arthritis
APMIS, 103 (3), 233-40
DOI 10.1111/j.1699-0463.1995.tb01100.x, PubMed 7755980

Brandtzaeg P, Gabrielsen TO, Dale I, Müller F, Steinbakk M, Fagerhol MK (1995)
The leucocyte protein L1 (calprotectin): a putative nonspecific defence factor at epithelial surfaces
Adv Exp Med Biol, 371A, 201-6
DOI 10.1007/978-1-4615-1941-6_41, PubMed 8525906

Brun JG, Ulvestad E, Fagerhol MK, Jonsson R (1994)
Effects of human calprotectin (L1) on in vitro immunoglobulin synthesis
Scand J Immunol, 40 (6), 675-80
DOI 10.1111/j.1365-3083.1994.tb03523.x, PubMed 7997858

Müller F, Frøland SS, Aukrust P, Fagerhol MK (1994)
Elevated serum calprotectin levels in HIV-infected patients: the calprotectin response during ZDV treatment is associated with clinical events
J Acquir Immune Defic Syndr (1988), 7 (9), 931-9
PubMed 7914232

Fosse E, Moen O, Johnson E, Semb G, Brockmeier V, Mollnes TE, Fagerhol MK, Venge P (1994)
Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass
Ann Thorac Surg, 58 (2), 472-7
DOI 10.1016/0003-4975(94)92231-4, PubMed 8067851

Moen O, Fosse E, Bråten J, Andersson C, Fagerhol MK, Venge P, Høgåsen K, Mollnes TE (1994)
Roller and centrifugal pumps compared in vitro with regard to haemolysis, granulocyte and complement activation
Perfusion, 9 (2), 109-17
DOI 10.1177/026765919400900205, PubMed 7919596

Pekna M, Borowiec J, Fagerhol MK, Venge P, Thelin S (1994)
Biocompatibility of heparin-coated circuits used in cardiopulmonary bypass
Scand J Thorac Cardiovasc Surg, 28 (1), 5-11
DOI 10.3109/14017439409098703, PubMed 7939508

Røseth AG, Kristinsson J, Fagerhol MK, Schjønsby H, Aadland E, Nygaard K, Roald B (1993)
Faecal calprotectin: a novel test for the diagnosis of colorectal cancer?
Scand J Gastroenterol, 28 (12), 1073-6
DOI 10.3109/00365529309098312, PubMed 8303210

Garred P, Fosse E, Fagerhol MK, Videm V, Mollnes TE (1993)
Calprotectin and complement activation during major operations with or without cardiopulmonary bypass
Ann Thorac Surg, 55 (3), 694-9
DOI 10.1016/0003-4975(93)90277-o, PubMed 8452432

Leren TP, Fagerhol MK, Leren P (1993)
Sixteen years of plasma exchange in a homozygote for familial hypercholesterolaemia
J Intern Med, 233 (2), 195-200
DOI 10.1111/j.1365-2796.1993.tb00673.x, PubMed 8433081

Hetland G, Berntzen HB, Fagerhol MK (1992)
Levels of calprotectin (leukocyte L1 protein) during apheresis
Scand J Clin Lab Invest, 52 (6), 479-82
DOI 10.3109/00365519209090124, PubMed 1411260

Røseth AG, Fagerhol MK, Aadland E, Schjønsby H (1992)
Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study
Scand J Gastroenterol, 27 (9), 793-8
DOI 10.3109/00365529209011186, PubMed 1411288

Brun JG, Haga HJ, Bøe E, Kallay I, Lekven C, Berntzen HB, Fagerhol MK (1992)
Calprotectin in patients with rheumatoid arthritis: relation to clinical and laboratory variables of disease activity
J Rheumatol, 19 (6), 859-62
PubMed 1404121

Berner Berntzen H, Endresen GK, Fagerhol MK, Spiechowicz J, Mowinckel P (1991)
Calprotectin (the L1 protein) during surgery in patients with rheumatoid arthritis
Scand J Clin Lab Invest, 51 (7), 643-50
DOI 10.3109/00365519109104575, PubMed 1810024

Semb AG, Gabrielsen TO, Halstensen TS, Fagerhol MK, Brandtzaeg P, Vaage J (1991)
Cardiac surgery and distribution of the leukocyte L1 protein-calprotectin
Eur J Cardiothorac Surg, 5 (7), 363-7
DOI 10.1016/1010-7940(91)90053-m, PubMed 1892665

Berntzen HB, Olmez U, Fagerhol MK, Munthe E (1991)
The leukocyte protein L1 in plasma and synovial fluid from patients with rheumatoid arthritis and osteoarthritis
Scand J Rheumatol, 20 (2), 74-82
DOI 10.3109/03009749109165280, PubMed 1709519

Berntzen HB, Fagerhol MK, Ostensen M, Mowinckel P, Høyeraal HM (1991)
The L1 protein as a new indicator of inflammatory activity in patients with juvenile rheumatoid arthritis
J Rheumatol, 18 (1), 133-8
PubMed 2023183

Dunlop O, Bruun JN, Myrvang B, Fagerhol MK (1991)
Calprotectin in cerebrospinal fluid of the HIV infected: a diagnostic marker of opportunistic central nervous system infection?
Scand J Infect Dis, 23 (6), 687-9
DOI 10.3109/00365549109024294, PubMed 1815329

Berntzen HB, Fagerhol MK (1990)
L1, a major granulocyte protein; isolation of high quantities of its subunits
Scand J Clin Lab Invest, 50 (7), 769-74
DOI 10.1080/00365519009091071, PubMed 2293338

Steinbakk M, Naess-Andresen CF, Lingaas E, Dale I, Brandtzaeg P, Fagerhol MK (1990)
Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin
Lancet, 336 (8718), 763-5
DOI 10.1016/0140-6736(90)93237-j, PubMed 1976144

Bell H, Schrumpf E, Fagerhol MK (1990)
Heterozygous MZ alpha-1-antitrypsin deficiency in adults with chronic liver disease
Scand J Gastroenterol, 25 (8), 788-92
DOI 10.3109/00365529008999216, PubMed 2402584

Berntzen HB, Munthe E, Fagerhol MK (1989)
A longitudinal study of the leukocyte protein L1 as an indicator of disease activity in patients with rheumatoid arthritis
J Rheumatol, 16 (11), 1416-20
PubMed 2600939

Berntzen HB, Fagerhol MK (1988)
L1, a major granulocyte protein: antigenic properties of its subunits
Scand J Clin Lab Invest, 48 (7), 647-52
DOI 10.3109/00365518809085785, PubMed 3144035

Brandtzaeg P, Jones DB, Flavell DJ, Fagerhol MK (1988)
Mac 387 antibody and detection of formalin resistant myelomonocytic L1 antigen
J Clin Pathol, 41 (9), 963-70
DOI 10.1136/jcp.41.9.963, PubMed 3056988

Andersson KB, Sletten K, Berntzen HB, Dale I, Brandtzaeg P, Jellum E, Fagerhol MK (1988)
The leucocyte L1 protein: identity with the cystic fibrosis antigen and the calcium-binding MRP-8 and MRP-14 macrophage components
Scand J Immunol, 28 (2), 241-5
DOI 10.1111/j.1365-3083.1988.tb02437.x, PubMed 3413449

Fagerhol MK (1988)
[AIDS testing on a large scale is needed in the fight against the epidemic]
Tidsskr Nor Laegeforen, 108 (5), 421
PubMed 3353942

Berntzen HB, Munthe E, Fagerhol MK (1988)
The major leukocyte protein L1 as an indicator of inflammatory joint disease
Scand J Rheumatol Suppl, 76, 251-6
DOI 10.3109/03009748809102976, PubMed 3251353

Brandtzaeg P, Dale I, Fagerhol MK (1987)
Distribution of a formalin-resistant myelomonocytic antigen (L1) in human tissues. II. Normal and aberrant occurrence in various epithelia
Am J Clin Pathol, 87 (6), 700-7
DOI 10.1093/ajcp/87.6.700, PubMed 3296737

Brandtzaeg P, Dale I, Fagerhol MK (1987)
Distribution of a formalin-resistant myelomonocytic antigen (L1) in human tissues. I. Comparison with other leukocyte markers by paired immunofluorescence and immunoenzyme staining
Am J Clin Pathol, 87 (6), 681-99
DOI 10.1093/ajcp/87.6.681, PubMed 2438925

Gjesdal K, Orstavik I, Fagerhol M, Endresen K, Reikvam A, Ulstrup JC, Sivertssen E (1987)
Blood donor selection can prevent cytomegalovirus infection after open heart surgery
Eur Heart J, 8 (4), 378-81
DOI 10.1093/oxfordjournals.eurheartj.a062290, PubMed 3038552

Gabrielsen TO, Dale I, Brandtzaeg P, Hoel PS, Fagerhol MK, Larsen TE, Thune PO (1986)
Epidermal and dermal distribution of a myelomonocytic antigen (L1) shared by epithelial cells in various inflammatory skin diseases
J Am Acad Dermatol, 15 (2 Pt 1), 173-9
DOI 10.1016/s0190-9622(86)70152-7, PubMed 2427557

Belenko M, Chanana AD, Joel DD, Fagerhol MK, Janoff A (1986)
Tracing the leukocyte marker protein in lung fluids and lung-draining lymph nodes during endotoxemia in sheep
Am Rev Respir Dis, 133 (5), 866-74
PubMed 3518558

Skjønsberg OH, Kierulf P, Gravem K, Fagerhol MK, Godal HC (1986)
Contaminating fibrin in CPD-blood: solubility in plasma and distribution in blood components following separation
Thromb Res, 41 (1), 1-8
DOI 10.1016/0049-3848(86)90274-4, PubMed 3961724

Skjønsberg OH, Kierulf P, Fagerhol MK, Godal HC (1986)
Thrombin generation during collection and storage of blood
Vox Sang, 50 (1), 33-7
DOI 10.1111/j.1423-0410.1986.tb04842.x, PubMed 3953021

Dale I, Brandtzaeg P, Fagerhol MK, Scott H (1985)
Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leukocytes. Immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin
Am J Clin Pathol, 84 (1), 24-34
DOI 10.1093/ajcp/84.1.24, PubMed 2409791

Mørland B, Fagerhol MK, Mørland J (1985)
Decreased Fc-receptor binding in human monocytes exposed to ethanol in vitro
Alcohol, 2 (3), 425-8
DOI 10.1016/0741-8329(85)90108-9, PubMed 4026959

Stockley RA, Dale I, Hill SL, Fagerhol MK (1984)
Relationship of neutrophil cytoplasmic protein (L1) to acute and chronic lung disease
Scand J Clin Lab Invest, 44 (7), 629-34
DOI 10.3109/00365518409083622, PubMed 6531650

Møller P, Fagerhol MK (1984)
Pi phenotypes in patients with ankylosing spondylitis, acute anterior uveitis, psoriasis and chronic prostatitis
Clin Genet, 26 (4), 339-41
DOI 10.1111/j.1399-0004.1984.tb01069.x, PubMed 6333942

Sander J, Fagerhol MK, Bakken JS, Dale I (1984)
Plasma levels of the leucocyte L1 protein in febrile conditions: relation to aetiology, number of leucocytes in blood, blood sedimentation reaction and C-reactive protein
Scand J Clin Lab Invest, 44 (4), 357-62
DOI 10.3109/00365518409083820, PubMed 6463565

Dale I, Fagerhol MK, Frigård M (1983)
Quantitation of a highly immunogenic leukocyte antigen (L1) by radioimmunoassay: methodological evaluation
J Immunol Methods, 65 (1-2), 245-55
DOI 10.1016/0022-1759(83)90321-6, PubMed 6418818

Holt J, Bangstad HJ, Fagerhol MK (1983)
[Fetomaternal hemorrhage]
Tidsskr Nor Laegeforen, 103 (25), 1752-3
PubMed 6648908

Dale I, Fagerhol MK, Naesgaard I (1983)
Purification and partial characterization of a highly immunogenic human leukocyte protein, the L1 antigen
Eur J Biochem, 134 (1), 1-6
DOI 10.1111/j.1432-1033.1983.tb07522.x, PubMed 6861753

ANKER E, ABILDGAARD U, ANDERSEN R, FAGERHOL M, BJUNE G (1983)
LOW ANTI-THROMBIN IN SEVERE DISEASE - CONSUMPTION OR DECREASED SYNTHESIS
SCAND J HAEMATOL, 30 39, 59-63

Maartmann-Moe K, Stenerud O, Fagerhol MK, Solberg LA, Torsvik H, Leren P (1982)
Plasma exchange in two "receptor negative" homozygotes for autosomal, dominant hypercholesterolemia
J Oslo City Hosp, 32 (5-6), 55-65
PubMed 6284897

Hug G, Chuck G, Fagerhol MK (1981)
PiPclifton: a new alpha 1-antitrypsin allele in an American Negro family
J Med Genet, 18 (1), 43-5
DOI 10.1136/jmg.18.1.43, PubMed 6973024

Hug G, Chuck G, Bowles B, Fagerhol MK (1980)
PiZpratt: a new alpha 1-antitrypsin allele in an American Negro family
Hum Genet, 56 (1), 107-10
DOI 10.1007/BF00281578, PubMed 6970715

Fagerhol MK, Dale I, Andersson T (1980)
A radioimmunoassay for a granulocyte protein as a marker in studies on the turnover of such cells
Bull Eur Physiopathol Respir, 16 Suppl, 273-82
DOI 10.1016/b978-0-08-027379-2.50028-4, PubMed 7225633

Hug G, Chuck G, Slemmer TM, Fagerhol MK (1980)
Pi Ecincinnati: a new alpha 1-antitrypsin allele in three Negro families
Hum Genet, 54 (3), 361-4
DOI 10.1007/BF00291583, PubMed 6967446

Gulsvik A, Fagerhol MK (1979)
Alpha 1-antitrypsin phenotypes and obstructive lung disease in the city of Oslo
Scand J Respir Dis, 60 (5), 267-74
PubMed 316573

Fylling P, Fagerhol M (1979)
Experience with two different medicated intrauterine devices: a comparative study of the Progestasert and Nova-T
Fertil Steril, 31 (2), 138-41
DOI 10.1016/s0015-0282(16)43813-6, PubMed 761675

Jeppsson JO, Laurell CB, Fagerhol M (1978)
Properties of isolated human alpha1-antitrypsins of Pi types M, S and Z
Eur J Biochem, 83 (1), 143-53
DOI 10.1111/j.1432-1033.1978.tb12078.x, PubMed 304805

Sande HA, Fagerhol M, Molnar O, Foss OP, Torjesen P (1978)
Alpha-fetoprotein: a marker for threatened abortion
Int J Gynaecol Obstet, 16 (4), 293-5
DOI 10.1002/j.1879-3479.1979.tb00448.x, PubMed 86467

Aarskog D, Aarseth P, Fagerhol MK (1978)
Alpha-1-antitrypsin (Pi)-types in recurrent miscarriages
Clin Genet, 13 (1), 81-4
DOI 10.1111/j.1399-0004.1978.tb04132.x, PubMed 304773

Gjønnaess H, Munkeby I, Frølich W, Vennerød AM, Fagerhol MK (1978)
Effect of estrogen treatment on coagulation and fibrinolysis in postmenopausal women. With special reference to cold activation of factor VII
Gynecol Obstet Invest, 9 (2-3), 109-23
DOI 10.1159/000300974, PubMed 738649

Sande HA, Fagerhol M (1978)
Alpha-fetoprotein concentration in maternal serum and abortion via VA and PGF2alpha
Int J Gynaecol Obstet, 15 (5), 419-22
DOI 10.1002/j.1879-3479.1977.tb00723.x, PubMed 80339

Gedde-Dahl T, Hansteen IL, Fagerhol MK, Olaisen B (1978)
Regional chromosome 12 mapping: information from a family with a (12;21) reciprocal translocation
Cytogenet Cell Genet, 22 (1-6), 478-81
DOI 10.1159/000131002, PubMed 752526

Vennerod AM, Orstavik KH, Laake K, Fagerhol M, Ly B (1977)
Purification of human factor IX
Thromb Res, 11 (5), 663-72
DOI 10.1016/0049-3848(77)90024-x, PubMed 929514

Grimmer O, Fagerhol MK (1977)
Immunoelectrophoretic quantitation of antithrombin III. Electroimmunodiffusion in agarose gels containing heparin
Int J Pept Protein Res, 9 (2), 85-90
PubMed 402327

Ward AM, Pickering JD, Fagerhol MK, Martin JP (1977)
Pi (antitrypsin) typing methods. A comparison of acid starch-gel electrophoresis and isoelectric focusing
Hum Hered, 27 (4), 292-7
DOI 10.1159/000152881, PubMed 892809

Jordfald G, Fagerhol MK, Heistø H (1976)
The allergy tests "RIST" and "RAST" in evaluation of allergy in children below two years of age
J Oslo City Hosp, 26 (11), 91-4
PubMed 1003263

Odegärd OR, Fagerhol MK, Lie M (1976)
Heparin cofactor activity and antithrombin III concentration in plasma related to age and sex
Scand J Haematol, 17 (4), 258-62
DOI 10.1111/j.1600-0609.1976.tb01183.x, PubMed 63141

Fagerhol MK (1976)
The genetics of alpha-1-antitrypsin and its implications
Postgrad Med J, 52 Suppl 2, 73-83
PubMed 1086470

Gedde-Dahl T, Cook PJ, Fagerhol MK, Pierce JA (1975)
Improved estimate of the Gm-Pi linkage
Ann Hum Genet, 39 (1), 43-50
DOI 10.1111/j.1469-1809.1975.tb00106.x, PubMed 810069

Gjonnaess H, Fagerhol MK, Stormorken H (1975)
Studies on coagulation and fibrinolysis in blood from puerperal women with and without oestrogen treatment
Br J Obstet Gynaecol, 82 (2), 151-7
DOI 10.1111/j.1471-0528.1975.tb02214.x, PubMed 123756

Gedde-Dahl T, Cook PJ, Fagerhol MK, Pierce JA (1975)
The Gm-Pi linkage: a summary estimate
Birth Defects Orig Artic Ser, 11 (3), 157-8
PubMed 54196

Gjonnaess H, Fagerhol MK (1975)
Studies on coagulation and fibrinolysis in pregnancy, with special reference to cold activation of factor VII
Acta Obstet Gynecol Scand, 54 (4), 363-7
DOI 10.3109/00016347509156768, PubMed 1081809

Gedde-Dahl T, Cook PJ, Fagerhol MK, Pierce JA (1975)
The Gm-Pi linkage: a summary estimate
Cytogenet Cell Genet, 14 (3-6), 327-8
DOI 10.1159/000130373, PubMed 53124

Korvald E, Abildgaard U, Fagerhol MK (1974)
Major operations, hemostatic parameters and venous thrombosis
Thromb Res, 4 (1), 147-54
DOI 10.1016/0049-3848(74)90210-2, PubMed 4829665

Fontán G, Cordero JL, Nistal M, García-Rodríguez MC, Quero J, Ojeda JA, Fagerhol MK (1974)
[Neonatal cholestasis and deficiency of alpha-1-antitrypsin (author's transl)]
An Esp Pediatr, 7 (4), 354-61
PubMed 4214121

Gjonnaess H, Fagerhol MK (1974)
Studies on plasma coagulation and fibrinolysis during oral contraception of various types with special reference to cold activation of factor VII
Scand J Haematol, 12 (3), 232-40
DOI 10.1111/j.1600-0609.1974.tb00203.x, PubMed 4831827

Fagerhol MK (1974)
Alpha-1-antitrypsin deficiency in pulmonary and liver degeneration
Birth Defects Orig Artic Ser, 10 (4), 208-11
PubMed 4549776

Feigelson J, Pecau Y, Fagerhol M (1973)
[Alpha-1-antitrypsin deficiency in a patient with mucoviscidosis]
Nouv Presse Med, 2 (28), 1899-901
PubMed 4198946

Refvem O, Fagerhol MK, Abildgaard U (1973)
Changes in antithrombin 3 levels following cessation of anticoagulant therapy
Acta Med Scand, 193 (4), 307-9
DOI 10.1111/j.0954-6820.1973.tb10582.x, PubMed 4197871

Laake K, Gjonnaess H, Fagerhol MK (1973)
Components of the kallikrein-kinin system and the spontaneous cold activation of factor VII in human plasma
Acta Pharmacol Toxicol (Copenh), 33 (3), 229-40
DOI 10.1111/j.1600-0773.1973.tb02010.x, PubMed 4800785

Aagenaes O, Matlary A, Elgjo K, Munthe E, Fagerhol M (1972)
Neonatal cholestasis in alpha-1-antitrypsin deficient children. Clinical, genetic, histological and immunohistochemical findings
Acta Paediatr Scand, 61 (6), 632-42
DOI 10.1111/j.1651-2227.1972.tb15960.x, PubMed 4117022

Arnesen H, Fagerhol MK (1972)
2 -Macroglobulin, 1 -antitrypsin, and antithrombin III in plasma and serum during fibrinolytic therapy with urokinase
Scand J Clin Lab Invest, 29 (3), 259-63
DOI 10.3109/00365517209080240, PubMed 4114014

Bergsjö P, Fagerhol MK, Abildgaard U (1972)
Antithrombin 3 concentration in women using low-dosage progestogen for contraception
Am J Obstet Gynecol, 112 (7), 938-40
DOI 10.1016/0002-9378(72)90816-2, PubMed 4114468

Gedde-Dahl T, Fagerhol MK, Cook PJ, Noades J (1972)
Autosomal linkage between the Gm and Pi loci in man
Ann Hum Genet, 35 (4), 393-9
PubMed 5073686

Larsson-Cohn U, Fagerhol MK, Abildgaard U (1972)
Concentration of antithrombin 3 during combined and progestogen-only oral contraceptive treatment
Acta Obstet Gynecol Scand, 51 (4), 315-7
DOI 10.3109/00016347209156865, PubMed 4642717

Fagerhol MK, Abildgaard U, Kornstad L (1971)
Antithrombin-3 concentration and ABO blood-groups
Lancet, 2 (7725), 664-5
DOI 10.1016/s0140-6736(71)80109-5, PubMed 4105980

Heisto H, Julsrud AC, Ulstrup JC, Fagerhol MK (1971)
[Hepatitis associated antigen (HAA) and the blood transfusion. A follow-up study of recipients of blood from donors with HAA and antibody]
Tidsskr Nor Laegeforen, 91 (21), 1530-1
PubMed 5569811

Abildgaard U, Fagerhol MK (1971)
[Should oral contraceptives be discontinued before surgery or during illness?]
Tidsskr Nor Laegeforen, 91 (9), 667
PubMed 5576185

Fagerhol MK (1971)
[The Pi system, its genetics and its relations with diseases]
Poumon Coeur, 27 (1), 41-51
PubMed 5555975

Abildgaard U, Fagerhol MK, Egeberg O (1970)
Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in human plasma
Scand J Clin Lab Invest, 26 (4), 349-54
DOI 10.3109/00365517009046245, PubMed 4098730

Aarskog D, Fagerhol MK (1970)
Protease inhibitor (Pi) phenotypes in chromosome aberrations
J Med Genet, 7 (4), 367-70
DOI 10.1136/jmg.7.4.367, PubMed 4250980

Fagerhol M, Abildgaard V (1970)
[Antithrombin 3 concentration in the blood]
Nord Med, 84 (46), 1473
PubMed 4098091

Fagerhol MK, Abildgaard U (1970)
[Can the measurement of antithrombin-3 point out women who run the risk of thrombosis with the use of P-pills?]
Tidsskr Nor Laegeforen, 90 (16), 1559-60
PubMed 5457809

Fagerhol MK, Abildgaard U, Bergsjo P, Jacobsen JH (1970)
Oral contraceptives and low antithrombin-3 concentration
Lancet, 1 (7657), 1175
DOI 10.1016/s0140-6736(70)91248-1, PubMed 4194500

Fagerhol MK, Abildgaard U (1970)
Immunological studies on human antithrombin 3. Influence of age, sex and use of oral contraceptives on serum concentration
Scand J Haematol, 7 (1), 10-7
PubMed 4988538

Fagerhol MK, Jacobsen JH (1969)
Heterogeneity of the human haptoglobin 1-1 molecule by electrophoresis of serum in starch gels at pH 4.9
Vox Sang, 17 (2), 143-5
DOI 10.1111/j.1423-0410.1969.tb00384.x, PubMed 5360612

Fagerhol MK, Hauge HE (1969)
Serum Pi types in patients with pulmonary diseases
Acta Allergol, 24 (2), 107-14
DOI 10.1111/j.1398-9995.1969.tb03760.x, PubMed 4191350

Fagerhol MK (1969)
Quantitative studies on the inherited variants of serum alpha-1-antitrypsin
Scand J Clin Lab Invest, 23 (1), 97-103
DOI 10.3109/00365516909078092, PubMed 5363442

Fagerhol MK, Gedde-Dahl T (1969)
Genetics of the Pi serum types. Family studies of the inherited variants of serum alpha-1-antitrypsin
Hum Hered, 19 (4), 354-9
DOI 10.1159/000152238, PubMed 5366282

Fagerhol MK, Eriksson AW, Monn E (1969)
Serum Pi types in some Lappish and Finnish populations
Hum Hered, 19 (4), 360-4
DOI 10.1159/000152239, PubMed 5366283

Fagerhol MK, Tenfjord OW (1968)
Serum Pi types in some European, American, Asian and African populations
Acta Pathol Microbiol Scand, 72 (4), 601-8
DOI 10.1111/j.1699-0463.1968.tb00472.x, PubMed 5681806

Fagerhol MK, Hauge HE (1968)
The Pi phenotype MP. Discovery of a ninth allele belonging to the system of inherited variants of serum alpha 1 antitrypsin
Vox Sang, 15 (5), 396-400
DOI 10.1111/j.1423-0410.1968.tb04081.x, PubMed 5699691

Fagerhol MK, Laurell CB (1967)
The polymorphism of "prealbumins" and alpha-1-antitrypsin in human sera
Clin Chim Acta, 16 (2), 199-203
DOI 10.1016/0009-8981(67)90181-7, PubMed 4166396

Fagerhol MK (1967)
Serum Pi types in Norwegians
Acta Pathol Microbiol Scand, 70 (3), 421-8
DOI 10.1111/j.1699-0463.1967.tb01310.x, PubMed 6083387

Fagerhol MK, Braend M (1966)
Classification of human serum prealbumins after starch gel electrophoresis
Acta Pathol Microbiol Scand, 68 (3), 434-8
DOI 10.1111/apm.1966.68.3.434, PubMed 5959848

Fagerhol MK, Braend M (1965)
Serum prealbumin: polymorphism in man
Science, 149 (3687), 986-7
DOI 10.1126/science.149.3687.986, PubMed 5827347

FAGERHOL MK (1965)
[ERRONEOUS TYPING WITH THE ELDON CARD]
Tidsskr Nor Laegeforen, 85, 558-9
PubMed 14343698

Fagerhol MK, Harboe A, Hartmann O (1965)
Lack of ABO isoagglutinin response to influenza A2 infection
Bibl Haematol, 23, 526-8
DOI 10.1159/000384303, PubMed 5867138

Braend M, Efremov G, Fagerhol MK, Hartmann O (1965)
Albumin and transferrin variants in Norwegians
Hereditas, 53 (1), 137-42
DOI 10.1111/j.1601-5223.1965.tb01986.x, PubMed 5889233

Review articles

Lundberg JO, Hellström PM, Fagerhol MK, Weitzberg E, Roseth AG (2005)
Technology insight: calprotectin, lactoferrin and nitric oxide as novel markers of inflammatory bowel disease
Nat Clin Pract Gastroenterol Hepatol, 2 (2), 96-102
DOI 10.1038/ncpgasthep0094, PubMed 16265127

Poullis A, Foster R, Mendall MA, Fagerhol MK (2003)
Emerging role of calprotectin in gastroenterology
J Gastroenterol Hepatol, 18 (7), 756-62
DOI 10.1046/j.1440-1746.2003.03014.x, PubMed 12795745

Johne B, Fagerhol MK, Lyberg T, Prydz H, Brandtzaeg P, Naess-Andresen CF, Dale I (1997)
Functional and clinical aspects of the myelomonocyte protein calprotectin
Mol Pathol, 50 (3), 113-23
DOI 10.1136/mp.50.3.113, PubMed 9292145

Fagerhol MK, Cox DW (1981)
The Pi polymorphism: genetic, biochemical, and clinical aspects of human alpha 1-antitrypsin
Adv Hum Genet, 11, 1-62, 371-2
PubMed 6168185

Fagerhol MK, Laurell CB (1970)
The Pi system-inherited variants of serum alpha 1-antitrypsin
Prog Med Genet, 7, 96-111
PubMed 4911922